Shawn Leland
Directeur/Membre du Conseil chez Fore Biotherapeutics, Inc.
Postes actifs de Shawn Leland
Sociétés | Poste | Début | Fin |
---|---|---|---|
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | 01/09/2023 | - |
Directeur Général | 01/09/2023 | 29/02/2024 |
Historique de carrière de Shawn Leland
Anciens postes connus de Shawn Leland
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELEVATION ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/01/2019 | 05/01/2023 |
Directeur Général | 18/11/2020 | 05/01/2023 | |
Fondateur | 01/01/2019 | 05/01/2023 | |
Corporate Officer/Principal | 01/01/2019 | 18/11/2020 | |
President | 18/11/2020 | 05/01/2023 | |
VERASTEM, INC. | Corporate Officer/Principal | 01/09/2017 | 01/08/2019 |
ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2013 | 01/09/2017 |
Formation de Shawn Leland
Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ELEVATION ONCOLOGY, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Shawn Leland
- Expérience